Vogenx Rings the Opening Bell

About This Event

Vogenx (Nasdaq: VOGX), a clinical stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of important diseases associated with dysfunctions in human metabolism including post bariatric hypoglycemia and gastroparesis, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, James Green, CEO rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore